CVE:DMT Small Pharma (DMT) Stock Price, News & Analysis C$0.15 -0.01 (-6.25%) (As of 10/20/2023) Add Compare Share Share Today's RangeC$0.15▼C$0.1650-Day RangeC$0.15▼C$0.1552-Week RangeC$0.06▼C$0.22Volume1.89 million shsAverage Volume296,159 shsMarket CapitalizationC$50.37 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisEarningsHeadlinesInsider TradesStock AnalysisEarningsHeadlinesInsider Trades Get Small Pharma alerts: Email Address Ad Stansberry ResearchThe Last Time Stocks Looked Like This, They Didn’t Move For 16 YearsThere is nothing the Federal Reserve can do on September 18 to stop what's coming next for U.S. stocks.Click here to view my new presentation now. About Small Pharma Stock (CVE:DMT)Small Pharma Inc., a biotechnology company, focuses on developing short-duration psychedelic-assisted therapies for the treatment of mental health conditions. Its clinical program is based on N,N, dimethyltryptamine, a naturally occurring psychoactive molecule. The company's product includes SPL026, which is in clinical Phase IIa for the treatment of major depressive disorder; and SPL028, an injectable formulation of deuterated DMT, which is in Phase 1 clinical trial, as well as SPL801B, an oral dosage. Its preclinical stage programs include SPL029, an oral formulation of a tryptamine to treat depressive disorder. The company is headquartered in London, the United Kingdom. As of October 23, 2023, Small Pharma Inc. operates as a subsidiary of Cybin Inc.Read More DMT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart DMT Stock News HeadlinesAugust 30, 2024 | msn.comRevised GMP norms for small drug firms to be issued soon; to be effective DecemberAugust 28, 2024 | msn.comPsychedelics: A new hope for substance abuse treatmentSeptember 10, 2024 | Stansberry Research (Ad)Expert Who Predicted Lehman Collapse Issues Major New WarningHow The Boeing Disasters Could Hit Nvidia Investors You may have heard about Boeing planes falling apart midflight and catching fire. But, according to analyst Dan Ferris, there's something much darker going on here that could threaten Nvidia, the Magnificent 7, and the entire U.S. stock market.August 15, 2024 | msn.comBig Pharma "unleashed an army" of lawyers to avoid lowering Medicare drug costs: reportAugust 15, 2024 | msn.comMost Patients With MS Have No Risk for Relapse After COVID-19 VaccinationAugust 14, 2024 | msn.comAtai's DMT Depression Drug Shows Promise, Prepares For Phase II Trial And Future Collaboration With Pharma GiantAugust 1, 2024 | msn.comWe asked Mark Cuban how he's going to disrupt Big Pharma. He said it's pretty straightforward, actually.July 30, 2024 | msn.comPharma companies less concerned after hearing from US on negotiated prices for MedicareSeptember 10, 2024 | Stansberry Research (Ad)Expert Who Predicted Lehman Collapse Issues Major New WarningHow The Boeing Disasters Could Hit Nvidia Investors You may have heard about Boeing planes falling apart midflight and catching fire. But, according to analyst Dan Ferris, there's something much darker going on here that could threaten Nvidia, the Magnificent 7, and the entire U.S. stock market.July 25, 2024 | yahoo.comMillions are trying FDA-authorized alternatives to Big Pharma’s weight loss drugsJuly 20, 2024 | msn.comWhy millions are trying alternatives to Big Pharma's weight loss drugsApril 26, 2024 | msn.comA shortcut for drug discovery: Novel method predicts on a large scale how small molecules interact with proteinsApril 26, 2024 | msn.comTech bros love talking about microdosing - but the legality of psychedelics is a messy grey areaApril 10, 2024 | forbes.comNavigating The Cookieless Era: How Pharma Adapts To Continual DisruptionApril 8, 2024 | msn.comFSD Pharma receives Nasdaq notification regarding minimum bid price deficiencyMarch 26, 2024 | finance.yahoo.comJuvisé Pharmaceuticals Acquires Multiple Sclerosis Drug PONVORY® (ex-US/Canada) and Opens Its Capital to Bpifrance and PembertonMarch 13, 2024 | msn.comLGM Pharma unveils enhanced analytical testing services and expands CDMO portfolio with additional suppository manufacturing capabilitiesMarch 9, 2024 | businessinsider.comPharmaceutical companies behind weight-loss drugs are slimming down a new target: The Magnificent 7See More Headlines Receive DMT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Small Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolCVE:DMT CUSIPN/A CIKN/A Webwww.smallpharma.co.uk Phone44 78 1212 1944FaxN/AEmployees13Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.07) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-19,310,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-116.90% Return on Assets-66.00% Debt Debt-to-Equity Ratio5.95 Current Ratio2.63 Quick Ratio6.28 Sales & Book Value Annual SalesC$-1,162.00 Price / Sales-43,343.80 Cash FlowC$0.13 per share Price / Cash Flow1.13 Book ValueC$0.03 per share Price / Book5.00Miscellaneous Outstanding Shares335,770,000Free FloatN/AMarket CapC$50.37 million OptionableNot Optionable Beta0.86 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesMr. George TzirasCEO & Non-Independent DirectorMr. David SteelChief Financial OfficerDr. Carol RoutledgeChief Scientific & Medical OfficerMs. Marie Claire Layzell (Age 46)Chief Manufacturing & Development Officer & Director Comp: $457.93kDr. Alastair James Riddell M.D. (Age 74)M.Sc., MBChB, MFPM, MRCGP, Ph.D., Chief Operating Officer Ms. Jenny MaguireHead of Brand & CommunicationsMs. Emma HodgeHead of Intellectual PropertyMr. Richard M. Kimel HBA (Age 56)LLB, Corporate Secretary Ms. Sarah HamiltonGroup Financial ControllerMr. Jim RennieDirector of Development and Member of Scientific & Advisory BoardMore ExecutivesKey CompetitorsFennec PharmaceuticalsTSE:FRXMedicenna TherapeuticsTSE:MDNABriaCell TherapeuticsCVE:BCTImmunoPrecise AntibodiesCVE:IPAScythian BiosciencesCVE:SCYBView All Competitors DMT Stock Analysis - Frequently Asked Questions How have DMT shares performed this year? Small Pharma's stock was trading at C$0.15 at the beginning of 2024. Since then, DMT shares have increased by 0.0% and is now trading at C$0.15. View the best growth stocks for 2024 here. How do I buy shares of Small Pharma? Shares of DMT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:DMT) was last updated on 9/10/2024 by MarketBeat.com Staff From Our PartnersYour Crypto Future is at StakeWhat if I told you that bananas could make you a millionaire? No, this isn't a joke – I'm talking about the...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredKamala’s Secret 3-Word Plan to Destroy America… Are You Prepared?America’s Slow Decline into Hell As Kamala Harris rises to power, her 3-word agenda threatens every America...Banyan Hill Publishing | SponsoredWarning For Nvidia HoldersHow The Boeing Disasters Could Hit Nvidia Investors You may have heard about Boeing planes falling apart mi...Stansberry Research | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredMike Huckabee Puts His Faith in This to Protect His RetirementMike Huckabee's Urgent Warning: Safeguard Your Financial Future NowAmerican Hartford Gold Group | SponsoredThe death of Nvidia?Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Small Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Small Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DMT Stock Alerts